19 research outputs found
Influence of production system in local and conventional pig breeds on stress indicators at slaughter, muscle and meat traits and pork eating quality
Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes
Approximately 27-36million patients in Europe have one of the similar to 5.000-8.000 known rare diseases. These patients often do not receive the care they need or they have a substantial delay from diagnosis to treatment. In March 2017, twenty-four European Reference Networks (ERNs) were launched with the aim to improve the care for these patients through cross border healthcare, in a way that the medical knowledge and expertise travels across the borders, rather than the patients. It is expected that through the ERNs, European patients with a rare disease get access to expert care more often and more quickly, and that research and guideline development will be accelerated resulting in improved diagnostics and therapies. The ERN on Genetic Tumour Risk Syndromes (ERN GENTURIS) aims to improve the identification, genetic diagnostics, prevention of cancer, and treatment of European patients with a genetic predisposition for cancer. The ERN GENTURIS focuses on syndromes such as hereditary breast cancer, hereditary colorectal cancer and polyposis, neurofibromatosis and more rare syndromes e.g. PTEN Hamartoma Tumour Syndrome, Li Fraumeni Syndrome and hereditary diffuse gastric cancer
Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes
Approximately 27–36 million patients in Europe have one of the ~ 5.000–8.000 known rare diseases. These patients often
do not receive the care they need or they have a substantial delay from diagnosis to treatment. In March 2017, twenty-four
European Reference Networks (ERNs) were launched with the aim to improve the care for these patients through cross
border healthcare, in a way that the medical knowledge and expertise travels across the borders, rather than the patients.
It is expected that through the ERNs, European patients with a rare disease get access to expert care more often and more
quickly, and that research and guideline development will be accelerated resulting in improved diagnostics and therapies.
The ERN on Genetic Tumour Risk Syndromes (ERN GENTURIS) aims to improve the identification, genetic diagnostics,
prevention of cancer, and treatment of European patients with a genetic predisposition for cancer. The ERN GENTURIS
focuses on syndromes such as hereditary breast cancer, hereditary colorectal cancer and polyposis, neurofibromatosis and
more rare syndromes e.g. PTEN Hamartoma Tumour Syndrome, Li Fraumeni Syndrome and hereditary diffuse gastric cancer
Influence of housing conditions on responses of pigs to preslaughter treatment and consequences for meat quality
The Fight-Or-Flight Response Is Associated with PBMC Expression Profiles Related to Immune Defence and Recovery in Swine
Solving the genetic aetiology of hereditary gastrointestinal tumour syndromes- a collaborative multicentre endeavour within the project Solve-RD
Réponses neuroendocriniennes de stress et caractéristiques de carcasse, comparaison de cinq races de porcs.
National audienc